ELECTRONIC ARTICLE |



* General Pediatrics Unit
Pediatrics Radiology Unit
|| Biostatistics Unit, Hôpital Necker Enfants Malades, Paris, France
Department of Otolaryngology Head Neck Surgery, Unité Centre National de la Recherche Scientifique UPRESSA 7060, Hôpital Europeen Georges Pompidou, Paris, France
| ABSTRACT |
|---|
|
|
|---|
Methods. We adapted for children an olfaction test that had just been validated in an adult French population and investigated a control group of 25 healthy children aged 6 to 13 years. We then tested the olfactory capacity of a group of 14 children with CHARGE syndrome, aged 6 to 18 years. A questionnaire was completed with the parents about their children's feeding difficulties and their ability to recognize odors in everyday life. We recorded and scored the histories of feeding behavior anomalies, the visual and auditory status, and current intellectual levels. MRI of the olfactory tracts and bulbs was analyzed for 9 of 14 children.
Results. We showed that healthy children have similar olfactory function to that of the adult control group, which was representative of the general population, without any difference for either gender or age. We also showed that all children with CHARGE syndrome had olfactory deficiency. Half of them were anosmic, and the others had olfactory residual function (hyposmic). We found no association between olfactory deficiency and feeding behavior, visual or auditory impairment, or intellectual level. Parental subjective evaluations were accurate for only half of the group. All of the MRIs showed anomalies of the olfactory tracts and bulbs varying from moderate hypoplasia to complete aplasia, without any relation between the radiologic and the functional results.
Conclusions. Olfaction can be assessed in children, even the young and disabled. Our results support the proposition that rhinencephalon anomalies should be included as a major criterion for the diagnosis of CHARGE syndrome.
Key Words: CHARGE syndrome olfaction in children olfactory deficiency
Abbreviations: CHARGE, coloboma, congenital heart disease, choanal atresia, mental and growth retardation, genital anomalies, and ear malformations and hearing loss PEA, phenylethylalcohol
Olfaction has always been and remains the most neglected sense in studies of child development and behavior, the main reasons being the poor knowledge concerning the role of olfaction in human development and behavior and the lack of available tools for investigating olfaction, in particular in children. Development of the olfactory system begins very early in the human embryo; olfactory bulbs have their definitive structure at day 56. Then, cells of the olfactory placode differentiate to gonadotropic cells and migrate to the hypothalamic region along the terminal nerve (cranial nerve 0), the olfactory nerve (cranial nerve 1), and the vomeronasal nerve. One part of the olfactory system projects to the anterior part of the hypothalamus for odor perception and discrimination; the other projects to the limbic system and the hippocampus for the behavioral impact of olfaction and olfactory emotional memory.1 The Jacobson vomeronasal organ is a fetal structure that reduces after birth and that allows the transmission of odors through aqueous middles, in particular amniotic fluid.2 Several data have shown that olfaction is functional during prenatal life.36 At birth, newborns have highly efficient olfactory abilities, allowing them to discriminate the odor of their mother's skin or milk from those of other mothers7,8 and to modify their feeding behavior according to the milk flavor.9,10 In mice, olfaction is crucial at birth to lead the pups to their mother's nipples, and anosmic mice die shortly after birth because they cannot find them.11 All of these data suggest that human neonatal olfaction probably plays a role both in mother-child bonding and in newborns' feeding behavior. During the first years of life, the role of olfaction is probably important, although few studies have demonstrated this, principally because olfaction evaluation is difficult in this age range. Nevertheless, in a previous study, we showed that reproducible behavioral modifications (breathing rhythm, mobility, and sight) indicate that healthy infants and toddlers (3 months to 3 years) have good olfaction abilities.12 Several studies have shown that olfaction improves from the age when it becomes testable (78 years of age) until the age of
40 years.1316 These observations may be attributable to the methods of olfaction testing and are discussed later. After puberty, girls have better olfaction abilities than boys.17,18 From the age of
40 years, olfaction abilities decrease, which partly explains anorexia in the elderly.18 The role of olfaction in adults is likely involved in several fields, such as appetite, emotional memory, and sexual bonding. However, few studies can prove these roles. Studies on behavior in adults with olfaction disorders, in particular patients with Kallmann syndrome, are rare and do not show major effects of hyposmia, suggesting that hyposmic patients compensate for their deficit by other sensorial and cognitive means.1921 Moreover, in humans, especially in Western and so-called developed cultures, the sense of smell is not well taught or stimulated.
CHARGE syndrome (coloboma, congenital heart disease, choanal atresia, mental and growth retardation, genital anomalies, and ear malformations and hearing loss) is a congenital malformative picture that was described 25 years ago.22,23 In addition to the defects cited in the acronym, other anomalies have been described. Some of them have a high frequency, such as vestibular anomalies, facial dysmorphism, asymmetrical facial palsy, and brainstem dysfunction, whereas others have a lower frequency, such as renal, esophageal, osseous, and cerebral malformations.2426 Once the structural anomalies are repaired, children with CHARGE have to overcome multiple sensory impairments, such as visual, auditory, and balance impairments. Olfaction has never been investigated in patients with CHARGE syndrome, although several arguments suggest that olfaction dysfunction is crucial in this malformative condition. First, most children with CHARGE syndrome have initial, severe, and long-lasting feeding disorders that are poorly explained by their swallowing disorders alone. Second, children with CHARGE syndrome may have genital anomalies as a result of hypothalamic luteinizing hormone-releasing hormone deficit.27 Some radiologic and anatomic data have already shown arhinencephaly in CHARGE syndrome.23,28 Finally, children with CHARGE syndrome often have peripheral orofacial anomalies that may impair olfaction, such as choanal atresia, cleft palate, or upper airway anomalies that sometimes lead to tracheotomy. We wanted to evaluate an additional sense (olfaction) in children with other multiple sensorial deficits. Thus, the aims of this study were dual: first, to explore an olfactory test adapted to young children (>5 years of mental age) or disabled children, and, second, to apply this test to a series of children with CHARGE syndrome.
| METHODS |
|---|
|
|
|---|
Patients With CHARGE Syndrome
Fourteen children with CHARGE syndrome were included. The group consisted of 8 girls aged 7.5 to 18 years (mean ± SD: 12.5 ± 4) and 6 boys aged 6 to 10 years (mean ± SD: 7.8 ± 1.4). The diagnosis of CHARGE syndrome was made according to Blake and Amiel's criteria (5 major criteria or 4 major criteria and 3 minor criteria30,31). We asked the families to participate when their child had speech and mental age corresponding to a 5- or 6-year level. Their visual ability had to be good enough to allow them to recognize drawings representing the odors on 10 10-cm pictures. Six patients had peripheral risk factors for olfaction deficit: patients 2 and 3 had cleft lip and palate; patients 2, 3, 8, and 9 had transient tracheostomy; and patients 5, 9, and 14 had unilateral choanal atresia. Patient 14 had previously been tested with a different method. She was excluded from the results but included in the association calculation and the discussion.
Parents and children of both groups all were volunteers for this prospective study. Consent of all of the families was obtained in accordance with the ethics rules of our hospital.
Olfactory Tests
The French Biolfa olfactory test, recently validated in healthy young adults, was adapted to children.29 The Biolfa test uses 2 series of 30-mL glass sniff bottles that contain odorous chemical substances. The first series measure the olfactory thresholds of 3 different substances (eugenol, aldehyde C14, and phenyl ethyl alcohol [PEA; quantitative trial]). The second series is an odor identification test to determine quality of olfactory function using a large panel of odors that are common to Southern European countries (qualitative trial).
Olfactory Thresholds
The threshold test consisted of aqueous dilutions of 3 components (eugenol, aldehyde C14, and PEA), the mean detection thresholds of which (0.5, 0.15, and 7.5 ppm, respectively) were published by the French Association for Normalization in 1989.32 These concentrations defined the level 3 on the difficulty scale of 9 concentration levels used in the test (Table 1). The lowest concentration at which 1 of these odors was detected was termed "detection threshold." In each test, we asked the child which of 2 stimuli (an odor or a blank), presented sequentially and in random order, smelled stronger (the forced-choice procedure). The first test began at the third level of difficulty. When a child failed to detect an odor, the next test was performed at the next higher concentration level. For normal patients, the threshold results are expressed in concentration (parts per million). This calculation cannot be used for anosmic patients because they cannot detect any odor (infinite threshold). Then, for analyzing the olfactory function in such cases, a test score was calculated for each component (eugenol, aldehyde C14, and PEA). For each child, the eugenol score was the value [1/eugenol threshold], the PEA score was the value [1/PEA threshold x 100], and the aldehyde C14 score was the value [1/aldehyde C14 threshold]. In anosmic patients, the olfaction threshold concentration tends to the infinite; thus, the test score tends to 0 and was estimated as 0.
|
Clinical Investigation in Patients With CHARGE Syndrome
In addition to the olfaction test, a questionnaire was discussed with the parents on their child's feeding difficulties and ability to smell and recognize odors in everyday life. This subjective evaluation of their olfactory capacity was scored at 3 levels: normal olfaction, residual olfaction, and no olfaction. Factors that are likely to decrease olfactory capacities, such as tracheostomy, choanal atresia, and cleft palate, were noted (even when they were no longer present at the study time). The severity of 2 other sense impairments (auditory and visual) was noted. Because the group was small, they were scored in 2 grades. For visual ability, "minor" impairment meant no coloboma, or unilateral coloboma, or bilateral coloboma but outside the macula and the papilla; "major " impairment meant large, bilateral coloboma, including the macula. For auditory ability, "minor" impairment meant hearing loss <60-dB deficit, and "major" impairment meant >60 dB. The severity of the feeding disorders was scored after analysis of the medical history, taking into account both the duration of artificial feeding (nasogastric tube or gastrostomy) and the abnormal feeding behavior (poor appetite and delay before achieving normal chewing and swallowing). Feeding disorders were scored in 4 grades: absent, minor, moderate, and major. The current intellectual status of the children with CHARGE was evaluated according to their school level, school system, and rehabilitation programs. They were scored in 5 classes, using a previous protocol, from class 0 (the best) to class 4 (the worst).33
Radiologic Data
For ethical reasons, brain MRI was not performed only for this study. However, we reanalyzed previous MRIs, only 9 of which pass through thin sections of coronal planes, correctly showing the olfactory tracts and bulbs. Olfactory bulb and tract anomalies were scored as follows: normal, moderate, or major hypoplasia or absent. The radiologist was blinded to the results of the olfactory tests.
Statistical Methods
To compare the olfactory thresholds of the children of the control group (n = 25) with the series of normal adults previously investigated (n = 52), we used the nonparametric Wilcoxon test. To compare children with CHARGE syndrome with the control group, because our sample was small, we used nonparametric tests, the Wilcoxon test for continuous data, and Fisher's exact test for categorical data. Fisher's exact tests were performed to test the relation among the olfactory deficiency and feeding disorders, current intellectual levels, and radiologic results. Concordance between objective olfaction test results and familial subjective evaluations was evaluated using the
coefficient.
| RESULTS |
|---|
|
|
|---|
|
|
|
5 years.
CHARGE Group
The control group and the group of children with CHARGE did not differ for age or gender.
Quantitative Evaluation
All children with CHARGE syndrome, except for 1, had severely decreased olfactory thresholds. One child has a detection threshold in the normal range for aldehyde C14 and PEA (7.5 and 0.15 ppm, respectively) but no detectable threshold for the third component. Nine of the 13 children who were tested by Biolfa (70%) had 0 detection scores. Detection scores differed highly between CHARGE and control children (Table 3).
|
|
|
To search for associations with the clinical parameters, because the sample was small, we divided the results of the children with CHARGE syndrome into 2 groups: anosmic and hyposmic. We did not find any statistical relation between olfactory test and clinical parameters. Comparison between subjective evaluation (parents' opinion) and objective results of the Biolfa test showed a poor concordance (
< 0). The parents' assessments agreed with the Biolfa results for only 6 of 13 children (patient 14 tested with another technique). Of the 6 children with peripheral risk factors for olfaction deficit, 3 were anosmic and 3 were hyposmic. This ratio was not different from that for the whole group. Surprising, we found no relation between the olfactory deficits and the severity of the feeding disorders. We found no association between the olfactory deficits and the current intellectual levels of the children, despite that all of the children of the low intellectual level groups were anosmic. However, children of the high intellectual level group could also have severe hyposmia or anosmia. We found no relation between the olfactory deficit and either visual or auditory impairment.
All 9 MRIs showed anomalies of the rhinencephalon. The olfactory tract and bulb anomalies varied from moderate hypoplasia to complete aplasia. No association could be found between the radiologic and the functional results.
| DISCUSSION |
|---|
|
|
|---|
The Biolfa test is an interesting tool for evaluating olfaction in normal children as well as in children with disabilities. Olfaction certainly has more influ-ence than we know on children's development and behavior, especially on feeding behavior and maybe on affective and psychological behavior. Olfaction is a primitive sense that is efficient early in life but receives no training and must be forgotten or neglected when higher methods of communication, especially speech, set in. Nevertheless, it might be interesting to look for olfactory dysfunction in children with disorders that affect appetite or behavior, such as nonorganic failure to thrive, for which the decrease in ingested food is often not understood, attention-deficit/hyperactivity disorder, and autism. Finally, the olfactory system could be impaired in children with congenital or acquired lesions of the forebrain or of the brain midline. Having an efficient test for olfactory evaluation may now change the pediatrician's approach to this question and lead to additional studies on the effects of introducing olfaction stimulation in rehabilitation programs for children with disabilities.
In CHARGE syndrome, olfaction seems to be a crucial question. In this series, olfactory deficiency and rhinencephalon radiologic anomalies were always present. Our sample of MRIs is small, but the results are very coherent. If this high frequency of radiologic rhinencephalon anomalies is confirmed in larger series, then this radiologic feature could become a major criterion for the diagnosis of CHARGEsyndrome. Rhinencephalon anomalies have already been described in CHARGE syndrome, at autopsy or in brain imaging, but these anomalies are not yet systematically sought.28 Thin sections of coronal planes, showing olfactory bulbs and tracts, are now recommended in brain imaging of patients who are suspected to have CHARGE syndrome. Rhinencephalon congenital anomalies are rare and are mostly observed in isolated congenital anosmia, holoprosencephaly spectrum, Kallmann de Morsier syndrome, and Johnson-McMillin syndrome. Isolated congenital anosmia is usually described in adults who complain of smell disorders late in life, and very few cases have been published in children.34,35 In this situation, the patients are otherwise healthy and the differential diagnosis of CHARGE syndrome is not considered. Johnson-McMillin is a rare autosomal dominant syndrome associated with alopecia, hypogonadotrophic hypogonadism, atresia of the external auditory canal, tooth defects, cardiac defects, and mental retardation. It induces embryologic anomalies of the ectoderm and neuroectoderm of the first and second brachial arches, Rathke's pouch, and the diencephalon.36,37 Overlaps between Johnson-McMillin and CHARGE syndrome exist because CHARGE syndrome also induces anomalies of neuroectoderm development and neural crest migration. Overlaps between CHARGE and Kallmann syndromes are interesting for several reasons. Kallmann syndrome, in its typical phenotype, is associated with hypogonadotropic hypogonadism and olfaction deficit. Some cases of Kallmann syndrome have been described with additional features such as hearing loss, choanal atresia, and mental retardation.38,39 In these situations, searching for semicircular canal anomalies could be useful to confirm or not CHARGE diagnosis. Moreover, endocrinologic anomalies of Kallmann syndrome are useful for understanding and investigating genital anomalies of patients with CHARGE syndrome. The lack of relationship that we found between functional and radiologic anomalies in CHARGE syndrome is not surprising, because the same observation has already been made in Kallmann neuroradiologic studies.40 Finally, several autosomal genes have been implicated in Kallmann syndrome and may be candidate regions when a mutation in the CHD7 gene has been excluded (
40% of the patients with CHARGE).4143
Our results suggest that olfactory deficiency of CHARGE syndrome is attributable not only to central anomalies but also to peripheral ones, which worsen olfactory function. We observed children with associated choanal atresia and different types of rhinencephalon radiologic anomalies. No child of this series had bilateral and complete choanal atresia, explaining why 2 of the 3 children with choanal atresia had residual olfactory abilities. Only bilateral choanal atresia has been shown to be responsible for anosmia in a small sample, suggesting that choanal atresia plays a deleterious role by its reduction of airflow through the olfactory nasal epithelium.44 Similarly, tracheotomy and cleft palate in children without central olfactory system anomalies have been incriminated in olfaction disorders.45,46
The consequences of olfactory deficiency in children with CHARGE syndrome are difficult to quantify because these children have multiple causes explaining their disabilities. That is probably why we did not find any association between olfactory deficiency and most clinical aspects of our series. A more subtle analysis than ours that focuses on the description of feeding behavior and cognitive function could provide more information. Hence, it is possible that olfactory deficiency participates in the phenotype of the affected children, especially regarding their feeding disorders, mother-child attachment, behavior disturbance, communication difficulties, and maybe cognitive outcome. When it becomes possible, evaluation of olfactory abilities of children with CHARGE syndrome should be included in the investigations that are used to analyze their disabilities. Even if olfactory deficiency cannot be measured in children who have CHARGE syndrome and whose mental age and speech level are below 5 years, radiologic data could suggest functional anomalies and lead to various suitable actions. First, olfactory deficiency has to be taken into account in the understanding of the abnormal feeding behavior of most children with CHARGE syndrome. For those who have major difficulties in achieving normal feeding behavior, especially difficulties in swallowing solids even after improvement of their organic swallowing disorders, it is likely that food texture plays an important role. Healthy children recognize and appreciate food by its visual aspect, taste, texture, and smell. If vision and olfaction are impaired, then children surely give more value to taste and texture. Their preference for salty or spicy tastes becomes understandable, as well as their preference for smooth textures. Moreover, children with olfaction dysfunction may benefit from rehabilitation programs. Sense of smell does not pass exclusively via olfactory bulbs, tracts, and nerve. Specific odors, such as lemon and vinegar, pass through the sensory branch of the fifth cranial nerve. In CHARGE syndrome, these odors should be preferred to odors that pass exclusively through the classical olfactory system. From early in life, olfactory residual capacities need to be stimulated by increasing the concentration of the fragrances that surround the child by giving him or her tasty food. Stimulation by games may educate their olfactory memory. Finally, olfaction must be part of the multisensorial stimulation programs that are essential for children with CHARGE syndrome.
| ACKNOWLEDGMENTS |
|---|
| FOOTNOTES |
|---|
Reprint requests to (V.A.) Hôpital Necker-Enfants Malades, 149 Rue de Sèvres, 75743 Paris Cedex 15, France. E-mail: veronique.abadie{at}nck.ap-hop-paris.fr
No conflict of interest declared.
| REFERENCES |
|---|
|
|
|---|
This article has been cited by other articles:
![]() |
D Sanlaville, H C Etchevers, M Gonzales, J Martinovic, M Clement-Ziza, A-L Delezoide, M-C Aubry, A Pelet, S Chemouny, C Cruaud, et al. Phenotypic spectrum of CHARGE syndrome in fetuses with CHD7 truncating mutations correlates with expression during human development J. Med. Genet., March 1, 2006; 43(3): 211 - 317. [Abstract] [Full Text] [PDF] |
||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||